The phase 3 DELTA TEEN trial evaluating Anzupgo 20 mg/g cream for the treatment of chronic hand eczema in adolescents has shown positive results, LEO Pharma announced in a press release. The 16-week, ...
Atopic dermatitis is one of the most common types of eczema. Signs may include inflamed skin, rash, itchiness and excessive dryness. It may also include bumps and swollen skin that may ooze. It ...
Diagnosis, treatment, lifestyle changes ... Hand dermatitis (HD), also known as hand eczema, is a common dermatologic disorder (Warshaw, Lee, & Storrs, 2003). It is a frequent problem among ...
This targeted daily treatment uses a 10% concentration of l-ascorbic acid, the purest form of vitamin C, which is an antioxidant capable of addressing several skin concerns related to premature skin ...
Moms in the U.S. are showing enthusiastic support for the Make America Healthy Again movement by promoting transparency, ...
Eczema, also known as atopic dermatitis, is a chronic inflammatory skin disease that can cause significant discomfort for ...
The market for chronic hand eczema is growing steadily due to the increasing prevalence of the condition, often caused by prolonged exposure to allergens, irritants, and harsh environmental factors.
18h
The Healthy on MSN9 Reasons You Keep Waking Up in the Middle of the NightWhen a bad dream isn’t to blame, consider one of these less obvious reasons you can’t sleep through the night. The post 9 ...
That endpoint was the Investigator’s Global Assessment for chronic hand eczema treatment success (IGA-CHE TS) at Week 16, with treatment success defined as an IGA-CHE score of 0 (clear) or 1 (almost ...
Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE). The launch of pan-JAK inhibitor Anzupgo (delgocitinib ...
The Solawave 2-in-1 Skincare Mini is a pocket-sized red light therapy device that's budget-friendly and perfect for beginners ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results